Effective and efficient use of implantable defibrillators: sometimes it's over when it's over.
作者信息
Dorian Paul
机构信息
Division of Cardiology, St. Michael's Hospital, University of Toronto, Toronto, Ont.
出版信息
CMAJ. 2009 Mar 17;180(6):599-600. doi: 10.1503/cmaj.090158.
Abstract
摘要
相似文献
1
Effective and efficient use of implantable defibrillators: sometimes it's over when it's over.
CMAJ. 2009 Mar 17;180(6):599-600. doi: 10.1503/cmaj.090158.
2
Maximum potential benefit of implantable defibrillators in preventing sudden death after hospital admission because of heart failure.植入式除颤器在预防因心力衰竭入院后猝死方面的最大潜在益处。
CMAJ. 2009 Mar 17;180(6):611-6. doi: 10.1503/cmaj.080769.
3
Implantable cardioverter-defibrillators.
N Engl J Med. 2005 May 12;352(19):2022-5; author reply 2022-5.
4
Important differences in mode of death between men and women with heart failure who would qualify for a primary prevention implantable cardioverter-defibrillator.在符合植入式心脏复律除颤器一级预防标准的心力衰竭男性和女性患者中，其死亡模式存在重要差异。
Circulation. 2012 Nov 13;126(20):2402-7. doi: 10.1161/CIRCULATIONAHA.111.069245. Epub 2012 Oct 16.
5
Sudden death in heart failure with preserved ejection fraction and beyond: an elusive target.射血分数保留的心力衰竭伴发心原性猝死：难以捉摸的靶点。
Heart Fail Rev. 2019 Nov;24(6):847-866. doi: 10.1007/s10741-019-09804-2.
6
Can implantable defibrillators reduce non-arrhythmic mortality?
J Interv Card Electrophysiol. 1998 Dec;2(4):371-5. doi: 10.1023/a:1009720906851.
7
Implantable cardioverter defibrillator for primary prevention in patients with severe ventricular dysfunction awaiting heart transplantation.用于等待心脏移植的严重心室功能不全患者一级预防的植入式心脏复律除颤器
Transplant Proc. 2013;45(10):3659-61. doi: 10.1016/j.transproceed.2013.10.017.
8
Heart failure devices: implantable cardioverter-defibrillators and biventricular pacing therapy.心力衰竭治疗设备：植入式心脏复律除颤器和双心室起搏治疗
Circulation. 2005 Jun 21;111(24):3327-35. doi: 10.1161/CIRCULATIONAHA.104.481267.
9
Outcomes After Implantable Cardioverter-Defibrillator Generator Replacement for Primary Prevention of Sudden Cardiac Death.用于心脏性猝死一级预防的植入式心脏复律除颤器发生器更换后的结局
Circ Arrhythm Electrophysiol. 2016 Mar;9(3):e003283. doi: 10.1161/CIRCEP.115.003283.
10
Resynchronizing ventricular contraction in heart failure.
N Engl J Med. 2005 Apr 14;352(15):1594-7. doi: 10.1056/NEJMe058065.
引用本文的文献
1
Usefulness of cardiac resynchronisation therapy devices and implantable cardioverter defibrillators in the treatment of heart failure due to severe systolic dysfunction: systematic review of clinical trials and network meta-analysis.心脏再同步治疗设备和植入式心脏复律除颤器在治疗严重收缩功能不全所致心力衰竭中的效用：临床试验的系统评价和网状Meta分析
Heart Asia. 2016 Jan 27;8(1):8-15. doi: 10.1136/heartasia-2015-010634. eCollection 2016.
2
Implantable cardioverter defibrillator therapy: a single center experience in saudi arabia.
Open Cardiovasc Med J. 2010 Sep 28;4:192-7. doi: 10.2174/1874192401004010192.
3
Device therapy: Who may and who may not benefit from an ICD?
Nat Rev Cardiol. 2011 Jan;8(1):10-2. doi: 10.1038/nrcardio.2010.183. Epub 2010 Nov 16.
4
[Treatment of progressive heart failure: pharmacotherapy, resynchronization (CRT), surgery].[进展性心力衰竭的治疗：药物治疗、再同步化治疗（CRT）、手术治疗]
Herz. 2010 Mar;35(2):94-101. doi: 10.1007/s00059-010-3329-z.
本文引用的文献
1
Maximum potential benefit of implantable defibrillators in preventing sudden death after hospital admission because of heart failure.植入式除颤器在预防因心力衰竭入院后猝死方面的最大潜在益处。
CMAJ. 2009 Mar 17;180(6):611-6. doi: 10.1503/cmaj.080769.
2
Implantable cardioverter-defibrillators after myocardial infarction.心肌梗死后的植入式心脏复律除颤器
N Engl J Med. 2008 Nov 20;359(21):2245-53. doi: 10.1056/NEJMra0803409.
3
The impact of implantable cardiac defibrillators for primary prophylaxis in the community: baseline risk and clinically meaningful benefits.植入式心脏除颤器用于社区一级预防的影响：基线风险和具有临床意义的益处。
J Eval Clin Pract. 2006 Apr;12(2):190-5. doi: 10.1111/j.1365-2753.2006.00616.x.
4
Canadian Cardiovascular Society/Canadian Heart Rhythm Society position paper on implantable cardioverter defibrillator use in Canada.加拿大心血管学会/加拿大心律学会关于加拿大植入式心脏复律除颤器使用的立场文件。
Can J Cardiol. 2005 May;21 Suppl A:11A-18A.
5
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.胺碘酮或植入式心脏复律除颤器用于治疗充血性心力衰竭。
N Engl J Med. 2005 Jan 20;352(3):225-37. doi: 10.1056/NEJMoa043399.
6
Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction.急性心肌梗死后植入式心脏复律除颤器的预防性应用。
N Engl J Med. 2004 Dec 9;351(24):2481-8. doi: 10.1056/NEJMoa041489.
7
Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction: a pooled analysis of 10 primary prevention trials.左心室收缩功能障碍患者的预防性植入式心脏复律除颤器治疗：10项一级预防试验的汇总分析
J Am Coll Cardiol. 2004 Dec 7;44(11):2166-72. doi: 10.1016/j.jacc.2004.08.054.
8
Mechanisms of death in the CABG Patch trial: a randomized trial of implantable cardiac defibrillator prophylaxis in patients at high risk of death after coronary artery bypass graft surgery.
Circulation. 1999 Mar 23;99(11):1416-21. doi: 10.1161/01.cir.99.11.1416.
9
Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators.冠状动脉搭桥手术后室性心律失常高危患者植入式心脏除颤器的预防性使用。冠状动脉搭桥（CABG）补片试验研究者。
N Engl J Med. 1997 Nov 27;337(22):1569-75. doi: 10.1056/NEJM199711273372201.
Zotero 插件